The acquisition battle between global pharmaceutical giants Pfizer and Novo Nordisk over the bio company Metsera is heating ...

The top China executive of US pharmaceutical company Eli Lilly and Co said on Wednesday that the company aims to make its ...

Viking Therapeutics is mispriced due to the successful but misunderstood clinical results of their oral GLP-1 treatment. Read ...

Metsera currently has no products on the market, but is developing oral and injectable treatments for obesity and diabetes.

Scripps Research in La Jolla announce a new clinical trial that will assess the effectiveness of using drugs approved for ...

Novo Nordisk attempts to acquire weight-loss drug company Metsera during government shutdown, potentially avoiding FTC ...

There’s plenty of reason to remain bullish on Novo Nordisk. Even with the challenges it has faced recently, the company ...

Eli Lilly is partnering with Walmart to offer Zepbound through its direct-to-consumer program, making the popular medication ...

Here are some companies that have moved to cut jobs recently. General Motors moved to lay off about 1,700 workers across ...

Los fármacos GLP-1, como Ozempic y Wegovy de Novo Nordisk, están diseñados para la autoadministración, mediante inyecciones semanales. Este hecho permitió al equipo de Scripps crear un ensayo clínico ...

Pfizer has decided to sue Metsera and Novo over $8.5B bid, citing antitrust risks and asserting regulatory advantage.